126 related articles for article (PubMed ID: 27285993)
1. Next-generation sequencing reveals germline mutations in an infant with synchronous occurrence of nephro- and neuroblastoma.
Theruvath J; Russo A; Kron B; Paret C; Wingerter A; El Malki K; Neu MA; Alt F; Staatz G; Stein R; Seidmann L; Prawitt D; Faber J
Pediatr Hematol Oncol; 2016 May; 33(4):264-75. PubMed ID: 27285993
[TBL] [Abstract][Full Text] [Related]
2. Multiple synchronous tumors in a child with Fanconi anemia.
Compostella A; Toffolutti T; Soloni P; Dall'Igna P; Carli M; Bisogno G
J Pediatr Surg; 2010 Feb; 45(2):e5-8. PubMed ID: 20152336
[TBL] [Abstract][Full Text] [Related]
3. Co-occurrence of neuroblastoma and nephroblastoma in an infant with Fanconi's anemia.
Bissig H; Staehelin F; Tolnay M; Avoledo P; Richter J; Betts D; Bruder E; Kühne T
Hum Pathol; 2002 Oct; 33(10):1047-51. PubMed ID: 12395380
[TBL] [Abstract][Full Text] [Related]
4. RFC-1 80G>A polymorphism in case-mother/control-mother dyads is associated with risk of nephroblastoma and neuroblastoma.
Montalvão-de-Azevedo R; Vasconcelos GM; Vargas FR; Thuler LC; Pombo-de-Oliveira MS; de Camargo B;
Genet Test Mol Biomarkers; 2015 Feb; 19(2):75-81. PubMed ID: 25536437
[TBL] [Abstract][Full Text] [Related]
5. Intragenic anaplastic lymphoma kinase (ALK) rearrangements: translocations as a novel mechanism of ALK activation in neuroblastoma tumors.
Fransson S; Hansson M; Ruuth K; Djos A; Berbegall A; Javanmardi N; Abrahamsson J; Palmer RH; Noguera R; Hallberg B; Kogner P; Martinsson T
Genes Chromosomes Cancer; 2015 Feb; 54(2):99-109. PubMed ID: 25251827
[TBL] [Abstract][Full Text] [Related]
6. Two siblings with familial neuroblastoma with distinct clinical phenotypes harboring an ALK germline mutation.
Kudo K; Ueno H; Sato T; Kubo K; Kanezaki R; Kobayashi A; Kamio T; Sasaki S; Terui K; Kurose A; Yoshida K; Shiozawa Y; Toki T; Ogawa S; Ito E
Genes Chromosomes Cancer; 2018 Dec; 57(12):665-669. PubMed ID: 30350464
[TBL] [Abstract][Full Text] [Related]
7. ALK germline mutations in patients with neuroblastoma: a rare and weakly penetrant syndrome.
Bourdeaut F; Ferrand S; Brugières L; Hilbert M; Ribeiro A; Lacroix L; Bénard J; Combaret V; Michon J; Valteau-Couanet D; Isidor B; Rialland X; Poirée M; Defachelles AS; Peuchmaur M; Schleiermacher G; Pierron G; Gauthier-Villars M; Janoueix-Lerosey I; Delattre O;
Eur J Hum Genet; 2012 Mar; 20(3):291-7. PubMed ID: 22071890
[TBL] [Abstract][Full Text] [Related]
8. Bilateral adrenal neuroblastoma and nephroblastoma occurring synchronously in a child with Fanconi's anemia and VACTERL syndrome.
Berrebi D; Lebras MN; Belarbi N; Couturier J; Fattet S; Faye A; Peuchmaur M; de Lagausie P
J Pediatr Surg; 2006 Jan; 41(1):e11-4. PubMed ID: 16410081
[TBL] [Abstract][Full Text] [Related]
9. Familial synchronous bilateral teratoid Wilms tumor with elevated alpha-fetoprotein level.
Okur A; Pinarli FG; Karadeniz C; Poyraz A; Fidan K; Basaklar C; Oguz A
Tumori; 2012 Nov; 98(6):179e-82e. PubMed ID: 23389381
[TBL] [Abstract][Full Text] [Related]
10. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma.
Janoueix-Lerosey I; Lequin D; Brugières L; Ribeiro A; de Pontual L; Combaret V; Raynal V; Puisieux A; Schleiermacher G; Pierron G; Valteau-Couanet D; Frebourg T; Michon J; Lyonnet S; Amiel J; Delattre O
Nature; 2008 Oct; 455(7215):967-70. PubMed ID: 18923523
[TBL] [Abstract][Full Text] [Related]
11. Germline gain-of-function mutations of ALK disrupt central nervous system development.
de Pontual L; Kettaneh D; Gordon CT; Oufadem M; Boddaert N; Lees M; Balu L; Lachassinne E; Petros A; Mollet J; Wilson LC; Munnich A; Brugière L; Delattre O; Vekemans M; Etchevers H; Lyonnet S; Janoueix-Lerosey I; Amiel J
Hum Mutat; 2011 Mar; 32(3):272-6. PubMed ID: 21972109
[TBL] [Abstract][Full Text] [Related]
12. Fanconi anemia gene mutations are not involved in sporadic Wilms tumor.
Adank MA; Segers H; van Mil SE; van Helsdingen YM; Ameziane N; van den Ouweland AM; Wagner A; Meijers-Heijboer H; Kool M; de Kraker J; Waisfisz Q; van den Heuvel-Eibrink MM
Pediatr Blood Cancer; 2010 Oct; 55(4):742-4. PubMed ID: 20589654
[TBL] [Abstract][Full Text] [Related]
13. Synchronous occurrence of acute lymphoblastic leukemia and wilms tumor in two patients: underlying etiology and combined treatment plan.
Yi JS; Kamihara J; Kesselheim JC; Davies K; van Hoff J; Silverman LB; Mullen EA
Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27862952
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous Adrenocortical Carcinoma and Neuroblastoma in an Infant With a Novel Germline p53 Mutation.
Courtney R; Ranganathan S
J Pediatr Hematol Oncol; 2015 Apr; 37(3):215-8. PubMed ID: 25374282
[TBL] [Abstract][Full Text] [Related]
15. Advances in the understanding of constitutional and somatic genomic alterations in neuroblastoma.
Deyell RJ; Attiyeh EF
Cancer Genet; 2011 Mar; 204(3):113-21. PubMed ID: 21504710
[TBL] [Abstract][Full Text] [Related]
16. Deep Sequencing Reveals Occurrence of Subclonal ALK Mutations in Neuroblastoma at Diagnosis.
Bellini A; Bernard V; Leroy Q; Rio Frio T; Pierron G; Combaret V; Lapouble E; Clement N; Rubie H; Thebaud E; Chastagner P; Defachelles AS; Bergeron C; Buchbinder N; Taque S; Auvrignon A; Valteau-Couanet D; Michon J; Janoueix-Lerosey I; Delattre O; Schleiermacher G
Clin Cancer Res; 2015 Nov; 21(21):4913-21. PubMed ID: 26059187
[TBL] [Abstract][Full Text] [Related]
17. Clinical feature of anaplastic lymphoma kinase-mutated neuroblastoma.
Ogura T; Hiyama E; Kamei N; Kamimatsuse A; Ueda Y; Ogura K
J Pediatr Surg; 2012 Oct; 47(10):1789-96. PubMed ID: 23084186
[TBL] [Abstract][Full Text] [Related]
18. Unraveling the Mystery: Next Generation Sequencing Sheds Light on Neuroblastoma Pathogenesis and Targeted Therapies.
Aktas T; Kızmazoglu D; Aktas S; Erol A; Serinan E; Gokbayrak O; Ozdemir SM; Altun Z; Ozer E; Cecen E; Ince D; Olgun N
Front Biosci (Landmark Ed); 2023 Aug; 28(8):171. PubMed ID: 37664946
[TBL] [Abstract][Full Text] [Related]
19. Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome.
Padovan-Merhar OM; Raman P; Ostrovnaya I; Kalletla K; Rubnitz KR; Sanford EM; Ali SM; Miller VA; Mossé YP; Granger MP; Weiss B; Maris JM; Modak S
PLoS Genet; 2016 Dec; 12(12):e1006501. PubMed ID: 27997549
[TBL] [Abstract][Full Text] [Related]
20. High ALK receptor tyrosine kinase expression supersedes ALK mutation as a determining factor of an unfavorable phenotype in primary neuroblastoma.
Schulte JH; Bachmann HS; Brockmeyer B; Depreter K; Oberthür A; Ackermann S; Kahlert Y; Pajtler K; Theissen J; Westermann F; Vandesompele J; Speleman F; Berthold F; Eggert A; Brors B; Hero B; Schramm A; Fischer M
Clin Cancer Res; 2011 Aug; 17(15):5082-92. PubMed ID: 21632861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
